---
title: "Evoque becomes first transcatheter tricuspid system to gain US FDA approval"
date: "2024-02-02T15:30:07.000Z"
publishedDate: "2 février 2024"
summary: "Edwards Lifesciences has announced that its Evoque tricuspid valve replacement system is the first transcatheter therapy to receive US Food and Drug Administration (FDA) approval for the treatment of tricuspid regurgitation (TR). The Evoque system is indicated for the improvement of health status in patients with symptomatic severe TR despite optimal medical therapy (OMT), for [&#8230;] The post Evoque becomes first transcatheter tricuspid system to gain US FDA approval appeared first on Cardiovascular News ."
importance: ""
sourceUrl: "https://cardiovascularnews.com/evoque-us-fda-approval/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2024-02-02-evoque-becomes-first-transcatheter-tricuspid-system-to-gain-us-fda-approval"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2023/10/EVOQUE_11_01_Hero_FINAL_091818__1.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/evoque-us-fda-approval/"
---

![Evoque becomes first transcatheter tricuspid system to gain US FDA approval](https://cardiovascularnews.com/wp-content/uploads/sites/14/2023/10/EVOQUE_11_01_Hero_FINAL_091818__1.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/evoque-us-fda-approval/*

## L’essentiel

Edwards Lifesciences has announced that its Evoque tricuspid valve replacement system is the first transcatheter therapy to receive US Food and Drug Administration (FDA) approval for the treatment of tricuspid regurgitation (TR). The Evoque system is indicated for the improvement of health status in patients with symptomatic severe TR despite optimal medical therapy (OMT), for [&#8230;] The post Evoque becomes first transcatheter tricuspid system to gain US FDA approval appeared first on Cardiovascular News .

## Lien source

https://cardiovascularnews.com/evoque-us-fda-approval/
